시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 신속 검사 시장 보고서(2025년)
Rapid Tests Global Market Report 2025
상품코드 : 1811017
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 신속 검사 시장 규모는 향후 수년간 급성장할 것으로 전망됩니다. 2029년까지 CAGR 11.3%로 확대되어 531억 7,000만 달러로 성장할 것으로 예상됩니다. 성장 요인으로는 가정용 검사 키트 사용률 증가, 개인화된 건강 관리에 대한 관심 증가, 개발 도상국의 신속 진단 수요 증가, 기존 임상 현장 이외의 이러한 검사의 광범위한 응용 등이 있습니다. 주요 새로운 동향으로는 마이크로유체 플랫폼의 진화, 검사 키트에 바이오센서 통합 향상, 멀티플렉스 검사 시스템의 진보, 진단 절차에 인공지능(AI) 응용, 휴대형 진단 기기의 혁신 등을 들 수 있습니다.

감염증 환자 수 증가가 신속 검사 시장의 확대에 기여하고 있습니다. 이 질병은 박테리아, 바이러스, 곰팡이, 기생충과 같은 유해한 유기체에 의해 유발되어 개인간에 쉽게 감염됩니다. 세계 이동 증가는 이러한 병원체의 신속한 확산을 촉진합니다. 신속 검사 솔루션은 의료 현장에서 정확하고 시기 적절한 진단을 제공하고 의료 제공업체가 신속하게 치료 및 봉쇄 조치를 시작할 수 있도록 함으로써 중요한 역할을 수행합니다. 진단 지연을 줄이고 질병 대응 노력을 강화하고 감염 전파를 억제하는데 필수적인 역할을 하고 있습니다. 예를 들어, 2024년 2월 영국 건강 안보국은 영국에서 결핵 환자가 10.7% 증가했으며 2022년 4,380명에서 2023년 4,850명으로 증가했다고 보고했습니다. 이 추세는 감염증 증가가 신속 검사 시장의 성장을 가속화하는 방법을 뒷받침합니다.

신속 검사 시장의 주요 기업은 보다 빠르고 민감한 미생물 검출을 가능하게 하는 생물 발광 기반 기술과 같은 하이테크 솔루션을 개발하고 있습니다. 이러한 첨단 기술은 발광하는 생화학 반응을 이용하는 것으로, 일반적으로 루시퍼라제 효소와 특정 기질이 관여하여 미생물과 생물학적 지표를 확인합니다. 예를 들어, 2025년 3월 미국을 기반으로 검사 서비스를 제공하는 Nelson Labs는 신속한 무균 검사법을 발표했습니다. 이 방법은 생물 발광을 이용하여 미생물의 ATP(생물 지표)를 검출하는 것으로, 반응 중에 방출되는 빛을 포착함으로써 기존 14일간의 배양 기간을 단 6일로 단축합니다. 이 시스템은 미생물 오염의 검출을 자동화하고, 검사의 정확성을 높이고, 규정 준수를 보장하며, 안전성을 손상시키지 않고 제품을 신속하게 출시할 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Rapid tests are diagnostic tools used for the quick detection of specific diseases or conditions, often delivering results within minutes to an hour. These tests do not require complex laboratory infrastructure, making them convenient and accessible. They are user-friendly, need minimal equipment, and can be administered at the point of care - such as clinics, pharmacies, or even at home. The primary function of rapid tests is to support immediate diagnostic decisions, enabling prompt treatment and aiding in disease control.

The main categories of rapid tests include instruments, consumables, and others. Instruments are devices used to analyze samples and encompass portable analyzers, benchtop analyzers, handheld devices, scanners or readers, and multiplex analyzers. These instruments are used to detect contaminants like pathogens, allergens, meat speciation, and pesticides, utilizing various technological methods such as polymerase chain reaction (PCR), immunoassay-based techniques, chromatography-based approaches, and spectroscopy-based tools. Rapid tests are widely used in cardiology, oncology, pregnancy and fertility, toxicology, glucose monitoring, infectious diseases, and more. The major end users of these tests include hospitals and clinics, diagnostic labs, home care settings, and other healthcare environments.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The rapid tests market research report is one of a series of new reports from The Business Research Company that provides rapid tests market statistics, including the rapid tests industry global market size, regional shares, competitors with the rapid tests market share, detailed rapid tests market segments, market trends, and opportunities, and any further data you may need to thrive in the rapid tests industry. This rapid test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The rapid tests market size has grown rapidly in recent years. It will grow from $31.07 billion in 2024 to $34.67 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. The growth during the historical period was fueled by an increasing occurrence of infectious diseases, heightened demand for diagnostics at the point of care, a growing emphasis on early detection, and a rising need for fast and precise test results, supported by enhanced healthcare expenditure and improved access.

The rapid tests market size is expected to see rapid growth in the next few years. It will grow to $53.17 billion in 2029 at a compound annual growth rate (CAGR) of 11.3%. Factors contributing to this future growth include the rising usage of at-home testing kits, growing attention toward personalized healthcare, increasing demand for rapid diagnostics in developing countries, and broader application of these tests beyond traditional clinical settings. Key emerging trends include the evolution of microfluidic platforms, improved integration of biosensors in testing kits, advancements in multiplex testing systems, the application of artificial intelligence (AI) in diagnostic procedures, and innovations in portable diagnostic equipment.

The growing number of infectious disease cases is contributing to the expansion of the rapid tests market. These diseases, caused by harmful organisms such as bacteria, viruses, fungi, or parasites, are easily transmitted between individuals. Increasing global mobility contributes to the faster spread of such pathogens. Rapid testing solutions play a critical role by providing accurate and timely diagnoses at the point of care, allowing healthcare providers to initiate treatment and containment measures promptly. They play an essential role in reducing diagnostic delays, enhancing disease response efforts, and curbing infection transmission. For example, in February 2024, the UK Health Security Agency reported that tuberculosis cases in England increased by 10.7%, rising from 4,380 cases in 2022 to 4,850 in 2023. This trend underscores how the rise in infectious diseases is accelerating the growth of the rapid tests market.

Leading companies in the rapid tests market are developing high-tech solutions like bioluminescence-based technologies that allow for quicker and more sensitive microbial detection. These advanced techniques use biochemical reactions that emit light, generally involving luciferase enzymes and specific substrates, to identify microorganisms or biological indicators. For instance, in March 2025, Nelson Labs, a US-based provider of testing services, introduced a rapid sterility testing method. This approach shortens the traditional 14-day incubation time to just six days using bioluminescence to detect microbial ATP-an indicator of living organisms-by capturing the emitted light during the reaction. The system automates microbial contamination detection, boosts testing precision, ensures compliance with regulations, and allows for quicker product release without compromising safety.

In June 2023, Avacta Group plc, a UK-based life sciences firm, completed the acquisition of Coris Bioconcept SRL for $13.21 million (£10.4 million). This acquisition allowed Avacta to broaden its footprint in the rapid diagnostics sector, enhance its capabilities in in vitro diagnostics (IVD), and leverage Coris's well-established portfolio of lateral flow tests and its international distribution channels. Coris Bioconcept SRL is a Belgium-based company specializing in the development and supply of rapid diagnostic tests.

Major players in the rapid tests market are Pfizer Inc., F. Hoffmann-La Roche AG, Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers, BioMerieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., PerkinElmer Inc., OraSure Technologies Inc., SEKISUI Diagnostics LLC, Trivitron Healthcare Pvt. Ltd., Ellume Limited, Access Bio Inc., ACON Laboratories Inc., CTK Biotech Inc., iHealth Labs Inc., Wondfo USA Co. Ltd., InBios International Inc., Lab Care Diagnostics India Pvt. Ltd., Immunostics Inc., Aptitude Medical Systems Inc., Nano-Ditech Corporation, Azure Biotech Inc., Beijing Hotgen Biotech Co. Ltd., CorDx Inc., Genabio Diagnostics Inc., Maxim Biomedical Inc., OSANG LLC, and Watmind USA.

North America was the largest region in the rapid tests market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in rapid tests report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the rapid tests market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The rapid tests market consists of revenues earned by entities by providing services such as point-of-care diagnostics, on-site screening, home-based testing, mobile health testing units, and diagnostic support for early disease detection and monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The rapid tests market also includes sales of rapid diagnostic kits, test strips, reagents, lateral flow assays, analyzers, and related consumables used for the detection of various diseases and conditions. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Rapid Tests Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on rapid tests market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for rapid tests ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The rapid tests market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Rapid Tests Market Characteristics

3. Rapid Tests Market Trends And Strategies

4. Rapid Tests Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Rapid Tests Growth Analysis And Strategic Analysis Framework

6. Rapid Tests Market Segmentation

7. Rapid Tests Market Regional And Country Analysis

8. Asia-Pacific Rapid Tests Market

9. China Rapid Tests Market

10. India Rapid Tests Market

11. Japan Rapid Tests Market

12. Australia Rapid Tests Market

13. Indonesia Rapid Tests Market

14. South Korea Rapid Tests Market

15. Western Europe Rapid Tests Market

16. UK Rapid Tests Market

17. Germany Rapid Tests Market

18. France Rapid Tests Market

19. Italy Rapid Tests Market

20. Spain Rapid Tests Market

21. Eastern Europe Rapid Tests Market

22. Russia Rapid Tests Market

23. North America Rapid Tests Market

24. USA Rapid Tests Market

25. Canada Rapid Tests Market

26. South America Rapid Tests Market

27. Brazil Rapid Tests Market

28. Middle East Rapid Tests Market

29. Africa Rapid Tests Market

30. Rapid Tests Market Competitive Landscape And Company Profiles

31. Rapid Tests Market Other Major And Innovative Companies

32. Global Rapid Tests Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Rapid Tests Market

34. Recent Developments In The Rapid Tests Market

35. Rapid Tests Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기